NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies.
Saved in:
| Title: | NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies. |
|---|---|
| Authors: | Kyvsgaard ER; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Department of Internal Medicine, Aalborg University Hospital Thisted, Thisted, Denmark., Grauslund M; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Sjø L; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Melchior LC; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Grantzau TL; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Gjerdrum LMR; Department of Pathology, Copenhagen University Hospital-Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Trab T; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark., Andersen LS; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Gang AO; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Breinholt M; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Pathology, Herlev Gentofte Hospital, Denmark., Møller MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Haaber Christensen J; Department of Hematology, Odense University Hospital, Odense, Denmark., Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark., Clausen MR; Department of Hematology, Vejle Sygehus, Vejle, Denmark., Riley CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Grønbæk K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Hutchings M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark. |
| Source: | American journal of hematology [Am J Hematol] 2025 Apr; Vol. 100 (4), pp. 712-716. Date of Electronic Publication: 2025 Jan 25. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
